Helena J Teede and colleagues’ global consensus to rename polycystic ovary syndrome (PCOS) as polyendocrine metabolic ovarian syndrome (PMOS) is an important advance.1 The previous term is ...

University of Pennsylvania doctor Anuja Dokras spent the last 14 years working to rename a common medical condition that can impact fertility in women, called polycystic ovary syndrome, or PCOS.

Polyendocrine metabolic ovarian syndrome (formerly known as PCOS) and infertility are linked, but it’s still possible to get ...

Last week, I wrote about the decade-long campaign to rename the condition known as polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS). The change recognizes that the ...

Credit: Getty Images We spoke with endocrinologists to explore the potential of artificial intelligence in the management of chronic disease, including diabetes, obesity, and PCOS. Artificial ...

A genomic analysis platform has been developed that can identify the genes behind rare endocrine disorders more quickly and accurately.

GPCR drug discovery and development specialist Confo Therapeutics NV has closed a €60 million (US$65.2 million) series B round that will fund a significant expansion of the inhouse portfolio while it ...

A new review was published in Volume 18 of Aging on June 11, 2026, titled "Age-related dysfunctions of the neuroendocrine ...